Osteoporosis: Review of the Evidence for Prevention, Diagnosis and Treatment and Cost-Effective Analysis

被引：0
作者：
机构：
来源：
Osteoporosis International | 1998年 / 8卷 / Suppl 4期
关键词：
Osteoporosis; Vertebral Fracture; Alendronate; Bone Mineral Density Testing; National Osteoporosis Foundation;
D O I：
10.1007/PL00022721
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：S7 / S80
相关论文
共 50 条
  • [41] Rethinking osteoporosis: Balancing risk and benefit in diagnosis, prevention, and treatment
    Smith, Alice
    Shaw, Brittany
    Laliberte, Danielle
    Langston, Jennifer
    Bushardt, Reamer L.
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (08): : 20 - 27
  • [42] Cost-effect pharmacology of osteoporosis treatment (review)
    Smirnov, SN
    Rubashek, IA
    Kochetkova, EA
    Geltser, BI
    TERAPEVTICHESKII ARKHIV, 2002, 74 (10) : 80 - 84
  • [43] Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464)
    N. C. Harvey
    E. McCloskey
    J. A. Kanis
    J. Compston
    C. Cooper
    Osteoporosis International, 2018, 29 : 1511 - 1513
  • [44] Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464)
    Harvey, N. C.
    McCloskey, E.
    Kanis, J. A.
    Compston, J.
    Cooper, C.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 (07) : 1511 - 1513
  • [45] Prevention of osteoporosis - A cost-effectiveness analysis regarding fractures
    Norlund, A
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1996, : 42 - 45
  • [46] Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
    Taheri, Saeed
    Fashami, Fatemeh Mirzayeh
    Peiravian, Farzad
    Yousefi, Nazila
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (02): : 1073 - 1085
  • [47] Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk
    de Bot, R. T. A. L.
    Veldman, H. D.
    Witlox, A. M.
    van Rhijn, L. W.
    Hiligsmann, M.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (07) : 1217 - 1229
  • [48] Minodronate in the treatment of osteoporosis A systematic review and meta-analysis
    Liu, Qingshan
    Chen, Dongmei
    Ye, Zongjian
    Jin, Zhaoming
    Ma, Tao
    Huang, Xuemei
    MEDICINE, 2020, 99 (40)
  • [49] Hip protectors are cost-effective in the prevention of hip fractures in patients with high fracture risk
    R.T.A.L. de Bot
    H.D. Veldman
    A.M. Witlox
    L.W. van Rhijn
    M. Hiligsmann
    Osteoporosis International, 2020, 31 : 1217 - 1229
  • [50] The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of OsteoporosisA Structured Review of the Literature
    Rachael L. Fleurence
    Cynthia P. Iglesias
    Jeanene M. Johnson
    PharmacoEconomics, 2007, 25 : 913 - 933
12345